Response to treatment of chronic hepatitis C with interferon α in patients infected with HIV-1 is associated with higher CD4+ cell count

Infection

Volumn 26, Issue 1, 1998, Pages 16-19

  Mauss, S ^a   Klinker, H ^c   Ulmer, A ^d   Willers, R ^b   Weissbrich B ^c   Albrecht, H ^e   Haussinger D ^b   Jablonowski, H ^b  

^a KIS Kuratorium fur Immunschwache   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d Rechenzentrum Univ Düsseldorf ^*  (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG TOXICITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; PATIENT; PATIENT SELECTION; REMISSION; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 0031985387     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02768746     Document Type: Article

References (24)

1. Forster, G. R., Thomas, H. C.: Hepatitis and other liver disease in patients with HIV infection. HIV: Adv. Res. Ther. 2 (1992) 19-24.
2. Eyster, E. M., Diamondstone, L. S., Lien, J. M., Ehmann, C., Quan, S., Godert, J. J.: Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. J. Aquir. Immune Defic. Syndr. 6 (1992) 602-610.
3. Telfer, P., Sabin, C., Devereux, H., Scott, F., Dusheiko, G., Lee, C.: The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br. J. Haematol. 87 (1994) 555-561.
4. Llibre, J. M., Garcia, E., Aloy, A., Valls, J.: Hepatitis C virus and progression of infection due to human immunodeficiency virus. Clin. Infect. Dis. 16 (1993) 182.
5. Quan, M. C., Krajden, M., Grigoriew, G. A., Salit, I. E.: Hepatitis C virus infection in patients infected with the human immunodeficiency virus. Clin. Infect. Dis. 17 (1993) 117-119.
6. Dorrucci, M., Pezzotti, P., Philips, A. N., Lepri, A. C., Rezza, G.: Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. J. Infect. Dis. 172 (1995) 1503-1508.
7. Sabin, A. C., Telfer, P., Philips, A. N., Bhagani, S., Lee, C. A.: The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men. J. Infect. Dis. 175 (1997) 164-168.
8. Di Bisceglie, A. M., Martin, P., Kassianides, C., Lisker-Melman, M., Murray, L., Waggoner, J., Goodman, Z., Banks, S. M., Hoofnagle, J. H.: Recombinant Interferon alfa therapy for chronic hepatitis C: a randomized double-blind, placebo-controlled trial. N. Engl. J. Med. 321 (1989) 1506-1510.
9. Davis, G. L., Balart, L., Schiff, E., Lindsay, K., Bodenheimer, H. C., Perrillo, R. P., Carey, W., Jacobson, I. M., Payne, J., Dienstag, J. L., van Thiel, D. H., Tamburro, C., Lefkowitch, J., Albrecht, J., Carlton, D., Meschievitz, C., Ortego, T. J., Gibas, A.: Treatment of chronic hepatitis C with recombinant Interferon alfa: a multicenter randomized trial. N. Engl. J. Med. 312 (1989) 1501-1506.
10. Boyer, N., Marcellin, P., Degott, C., Degos, F., Saimot, A. G., Erlinger, S., Benhamou, J. P.: Recombinant interferon-α for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. J. Infect. Dis. 165 (1992) 723-726.
11. Marriott, E., Navas, S., Del Romero, J., Garcia, S., Castillo, I., Quiroga, J. A., Carreno, V.: Treatment with recombinant alpha-interferon of chronic hepatitis C in anti-HIV-positive patients. J. Med. Virol. 40 (1993) 107-111.
12. Mauss, S., Heintges, T., Adams, O., Albrecht, H., Niederau, C., Jablonowski, H.: Treatment of chronic hepatitis C with interferon-α in patients infected with the human immunodeficiency virus. Hepato-Gastroenterology 42 (1995) 528-534.
13. Soriano, V., Garcia-Samaniego, J., Bravo, R., Castro, A., Odriozola, P. M., Gonzalez, J., Colmenero, M., Carballo, E., Suarez, D., Llibre, J. M., Alberdi, J. C., Pedreira, J., Gonzalez-Lahoz, J.: Efficacy and safety of α-interferon treatment for chronic hepatitis C in HIV-infected patients. J. Infect. 31 (1995) 9-13.
14. De Groote, J., Gedigk, P., Popper, H., Scheuer, P. J., Thaler, H., Desmet, V. J., Korb, G., Poulsen, H., Schmid, M., Uehlinger, E., Wepler, W.: A classification of chronic hepatitis. Lancet ii (1968) 626-628.
15. Poynard, T., Bedossa, P., Chevallier, M.: A comparison of three interferon alfa-2b regimens for the long-term treatment of non-A, non-B hepatitis. N. Engl. J. Med. 332 (1995) 1457-1462.
16. Soriano, V., Garcia-Samaniego, J., Bravo, R., Gonzalez, J., Castro, A., Castilla, J., Martinez-Odriozola, P., Colmenero, M., Carballo, E., Suarez, D., Rodriguez-Pinero, F. J., Moreno, A., Del Romero, J., Pedreira, J., Gonzalez-Lahoz, J.: Interferon alpha for the treatment of chronic hepatitis C in patients infected with the human immunodeficiency virus. Clin. Infect. Dis. 23 (1996) 585-591.
17. Davis, G. L.: Prediction of response to interferon treatment of chronic hepatitis C. J. Hepatol. 21 (1994) 1-3.
18. Hoofnagle, J. H., Bisceglie, A. M.: The treatment of chronic viral hepatitis. N. Engl. J. Med. 336 (1997) 347-356.
19. Podzamczer, D., Bolao, F., Garcia, P., Casanova, A., Pagerols, X., Gudiol, F.: Low-dose interferon alpha combined with zidovudine in patients with AIDS-associated Kaposi's sarcoma. J. Intern. Med. 233 (1993) 247-253.
20. Mauss, S., Jablonowski, H.: Efficacy, safety, and tolerance of low-dose, long-term interferon α 2b and zidovudine in early-stage AIDS-associated Kaposi's sarcoma. J. Acquir. Immune Defic. Syndr. 10 (1995) 157-162.
21. Preston, H., Wright, T. L.: Interferon therapy for hepatitis C. Lancet 348 (1996) 974-975.
22. Krown, S. E.: Interferon and other biologic agents for the treatment of Kaposi's sarcoma. Hematol. Oncol. Clin. North Am. 2 (1991) 311-323.
23. Diepolder, H. M., Zachoval, R., Hoffmann, R. M., Wierenga, E. A., Santantonio, T., Eichenlaub, D., Pape, G. R.: Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346 (1995) 1006-1007.
24. Missale, G., Bertoni, R., Lamonaca, V., Valli, A., Massari, A., Mori, C., Rumi, M. G., Houghton, M., Fiaccadori, F., Ferrari, C.: Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J. Clin. Invest. 98 (1996) 706-714.